by Brenda Baletti, Ph.D., Childrens Health Defense:

Dr. Meryl Nass told The Defender there have been other recent drug trials in which participants suffered serious adverse events similar to the one reported by Novavax — yet the trials were allowed to continue, and the drugs were approved.

The U.S. Food and Drug Administration (FDA) halted Novavax’s trial of its experimental COVID-19-flu combination vaccine and its standalone flu shot after a trial participant reported nerve damage, the company said today.